Identifying genetically driven gene dysregulation in Alzheimer's disease and related dementias using statistical data integration
使用统计数据整合识别阿尔茨海默病和相关痴呆症中遗传驱动的基因失调
基本信息
- 批准号:10659349
- 负责人:
- 金额:$ 67.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAreaAwarenessBiologicalBiological AssayBiological ProcessBrainBrain DiseasesBrain regionCell NucleusCell SeparationChromatinCodeComplexDataData SetDementiaDementia with Lewy BodiesDevelopmentDiseaseDrug TargetingEpigenetic ProcessFormulationFrontotemporal Lobar DegenerationsFutureGene ExpressionGenesGeneticGenetic VariationGenomeGenomic approachGenomicsGenotypeGoalsHeritabilityHumanInterventionLewy Body DementiaLinkage DisequilibriumMediatingMeta-AnalysisModelingMolecular ProfilingMultiomic DataOutcomePathway interactionsPositioning AttributePrefrontal CortexProteomeProteomicsRegulationResearchResourcesRiskRoleSchizophreniaSortingSpecificityTherapeutic InterventionTissuesTrainingUntranslated RNAVariantanalytical methodbiological heterogeneitybrain cellbrain tissuecausal variantcell typeclinical heterogeneitydata integrationdementia riskdisorder riskdrug developmentepigenetic profilingepigenomegenome wide association studygenome-widehistone modificationimprovedmulti-scale modelingneuropsychiatric disordernext generationnovelnovel strategiesonline resourcepsychopharmacologicrisk variantstatisticstraittranscriptometranscriptome sequencingtranscriptomic profilingtranscriptomics
项目摘要
PROJECT SUMMARY
Alzheimer’s disease (AD) and related dementias (ADRD) are highly heritable, severe, and complex brain
disorders. Molecular profiling efforts of the brain have enabled us to understand more about how common
variants may be associated with disease risk via regulating gene expression. However, the status quo as it
pertains to the use of multiomics data for gene-trait association, is limited to independent transcriptome- and
proteome-wide association studies. Here, we propose to: (1) additionally leverage epigenetic datasets and (2)
apply a data-driven correlation-aware meta-analytic approach to integrate a wide range of brain cell-type and
area specific imputed transcriptomes, proteomes and epigenomes. Our preliminary data suggest that this will
greatly increase the power to identify genetically driven gene dysregulation associated with these disorders while
controlling for the correlation between different genomic features.
First, we will impute brain cell-type (based on FANS/FACS-sorted and single-nucleus data) and brain area
(PFC, ACC, EC, STG, IFG) specific transcriptomes, proteomes and epigenomes for AD, frontotemporal lobar
degeneration, and dementia with Lewy bodies. Secondly, for each disease, we will perform a data-driven
correlation-aware meta-analysis of these imputed genomic features to identify key genes. Lastly, we will develop
an open resource that provides for the rapid dissemination and open access to analyses and outcomes. To our
knowledge, the proposed approach will result in the largest multiscale modeling of genetically driven gene
dysregulation in the brain, will identify novel genes associated with dementias and will enable similar studies in
other brain disorders as well.
项目摘要
阿尔茨海默病(AD)和相关痴呆(ADRD)是高度遗传的、严重的和复杂的脑损害
紊乱大脑的分子分析工作使我们能够更多地了解
变异可能通过调节基因表达与疾病风险相关。然而,现状是,
涉及使用多组学数据进行基因-性状关联,仅限于独立的转录组,
蛋白质组关联研究。在这里,我们建议:(1)另外利用表观遗传数据集和(2)
应用数据驱动的相关性感知元分析方法来整合广泛的脑细胞类型,
区域特异性估算转录组、蛋白质组和表观基因组。我们的初步数据显示,
大大增加了识别与这些疾病相关的遗传驱动基因失调的能力,
控制不同基因组特征之间的相关性。
首先,我们将估算脑细胞类型(基于FANS/FACS分类和单核数据)和脑面积
(PFC、ACC、EC、STG、IFG)特异性转录组、蛋白质组和表观基因组,
变性和路易体痴呆其次,对于每种疾病,我们将进行数据驱动的
这些估算的基因组特征的相关性感知荟萃分析,以确定关键基因。最后,我们将开发
一个开放的资源,提供快速传播和开放访问的分析和结果。对我们
知识,所提出的方法将导致最大的多尺度建模的基因驱动的基因
大脑中的失调,将确定与痴呆症相关的新基因,并将使类似的研究,
其他的脑部疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Georgios Voloudakis其他文献
Georgios Voloudakis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Georgios Voloudakis', 18)}}的其他基金
Characterizing and targeting subphenotypes of schizophrenia and bipolar disorder via individually imputed tissue and cell-type specific transcriptomes
通过单独估算的组织和细胞类型特异性转录组来表征和靶向精神分裂症和双相情感障碍的亚表型
- 批准号:
10659162 - 财政年份:2020
- 资助金额:
$ 67.08万 - 项目类别:
Characterizing and targeting subphenotypes of schizophrenia and bipolar disorder via individually imputed tissue and cell-type specific transcriptomes
通过单独估算的组织和细胞类型特异性转录组来表征和靶向精神分裂症和双相情感障碍的亚表型
- 批准号:
10431854 - 财政年份:2020
- 资助金额:
$ 67.08万 - 项目类别:
Characterizing and targeting subphenotypes of schizophrenia and bipolar disorder via individually imputed tissue and cell-type specific transcriptomes
通过单独估算的组织和细胞类型特异性转录组来表征和靶向精神分裂症和双相情感障碍的亚表型
- 批准号:
10166951 - 财政年份:2020
- 资助金额:
$ 67.08万 - 项目类别:
Characterizing and targeting subphenotypes of schizophrenia and bipolar disorder via individually imputed tissue and cell-type specific transcriptomes
通过单独估算的组织和细胞类型特异性转录组来表征和靶向精神分裂症和双相情感障碍的亚表型
- 批准号:
10055546 - 财政年份:2020
- 资助金额:
$ 67.08万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 67.08万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 67.08万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 67.08万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 67.08万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 67.08万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 67.08万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 67.08万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 67.08万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 67.08万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 67.08万 - 项目类别:














{{item.name}}会员




